Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma

Siegel, 2020, Cancer statistics, 2020, CA Cancer J. Clin., 70, 7, 10.3322/caac.21590 Ferlay, 2018, Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018, Eur. J. Cancer, 103, 356, 10.1016/j.ejca.2018.07.005 Chen, 2016, Cancer statistics in China, 2015, CA Cancer J. Clin., 66, 115, 10.3322/caac.21338 Kulik, 2019, Epidemiology and Management of Hepatocellular Carcinoma, Gastroenterology, 156, 477, 10.1053/j.gastro.2018.08.065 Singal, 2020, Epidemiology and surveillance for hepatocellular carcinoma: New trends, J. Hepatol., 72, 250, 10.1016/j.jhep.2019.08.025 McGlynn, 2020, Epidemiology of Hepatocellular Carcinoma, Hepatology Mak, 2020, Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance, J. Hepatol., 73, 952, 10.1016/j.jhep.2020.05.042 El-Khoueiry, 2017, Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial, Lancet, 389, 2492, 10.1016/S0140-6736(17)31046-2 Zhu, 2018, Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial, Lancet Oncol., 19, 940, 10.1016/S1470-2045(18)30351-6 Finn, 2020, Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial, J. Clin. Oncol., 38, 193, 10.1200/JCO.19.01307 Schmitt, 2016, Long Noncoding RNAs in Cancer Pathways, Cancer Cell, 29, 452, 10.1016/j.ccell.2016.03.010 Zhao, 2013, Long noncoding RNAs and their role in the liver cancer axis, Nat. Rev. Gastroenterol. Hepatol., 10, 703, 10.1038/nrgastro.2013.87-c1 Atianand, 2017, Immunobiology of Long Noncoding RNAs, Annu. Rev. Immunol., 35, 177, 10.1146/annurev-immunol-041015-055459 Chen, 2017, Gene regulation in the immune system by long noncoding RNAs, Nat. Immunol., 18, 962, 10.1038/ni.3771 Peng, 2019, An immune infiltration signature to predict the overall survival of patients with colon cancer, IUBMB Life, 71, 1760, 10.1002/iub.2124 Zhang, 2019, Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma, Ann. Transl. Med., 7, 730, 10.21037/atm.2019.11.117 Wei, 2020, Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour, EBioMedicine, 57, 102850, 10.1016/j.ebiom.2020.102850 Wei, 2019, Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer, J. Cell. Biochem., 120, 14916, 10.1002/jcb.28754 Wu, 2019, Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma, Front. Genet., 10, 1252, 10.3389/fgene.2019.01252 Jiang, 2020, Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma, Cancer Cell Int., 20, 166, 10.1186/s12935-020-01242-7 Song, 2020, Identification of an immune-relatedlLong non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer, Aging (Albany NY), 12, 12051, 10.18632/aging.103369 Lv, 2019, Landscape of cancer diagnostic biomarkers from specifically expressed genes, Brief. Bioinform. Zhu, 2016, A long non-coding RNA signature to improve prognosis prediction of gastric cancer, Mol. Cancer, 15, 60, 10.1186/s12943-016-0544-0 Qu, 2018, Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma, Eur. Urol., 74, 756, 10.1016/j.eururo.2018.07.032 Gruss, 2019, The Effects of Locality and Host Plant on the Body Size of Aeolothrips intermedius (Thysanoptera: Aeolothripidae) in the Southwest of Poland, Insects, 10, 266, 10.3390/insects10090266 Deng, 2020, Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma, Medicine (Baltimore), 99, e20422, 10.1097/MD.0000000000020422 Zhang, 2020, Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma, J. Cell. Physiol., 235, 9304, 10.1002/jcp.29730 Luzón-Toro, 2019, LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer, Sci. Rep., 9, 14374, 10.1038/s41598-019-50913-7 Huan, 2020, Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response, Mol. Cancer, 19, 11, 10.1186/s12943-019-1122-z Campbell, 2020, Thermal Bioprinting Causes Ample Alterations of Expression of LUCAT1, IL6, CCL26, and NRN1L Genes and Massive Phosphorylation of Critical Oncogenic Drug Resistance Pathways in Breast Cancer Cells, Front. Bioeng. Biotechnol., 8, 82, 10.3389/fbioe.2020.00082 Xu, 2018, Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer, Oncogene, 37, 5020, 10.1038/s41388-018-0308-y Li, 2020, Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation, Cell Death Dis., 11, 41, 10.1038/s41419-020-2232-7 Zhou, 2020, Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma, J. Oral Pathol. Med., 10.1111/jop.13074 Lu, 2017, Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis, Tumour Biol., 39, 10.1177/1010428317697574 Guo, 2019, Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1, Exp. Cell Res., 382, 111461, 10.1016/j.yexcr.2019.06.006 Yang, 2019, Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3, FASEB J., 33, 10490, 10.1096/fj.201802543RR You, 2020, YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis, Biomed. Pharmacother., 129, 110339, 10.1016/j.biopha.2020.110339 Jiao, 2019, Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways, J. Gastrointestin. Liver Dis., 28, 439, 10.15403/jgld-356 Hu, 2020, Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axis, Cancer Med., 9, 5620, 10.1002/cam4.3204 Wang, 2018, Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma, Cell Death Dis., 9, 851, 10.1038/s41419-018-0937-7 Sveen, 2012, ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients, Clin. Cancer Res., 18, 6001, 10.1158/1078-0432.CCR-11-3302 Garon, 2019, Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study, J. Clin. Oncol., 37, 2518, 10.1200/JCO.19.00934 Li, 2017, TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells, Cancer Res., 77, e108, 10.1158/0008-5472.CAN-17-0307 Li, 2020, TIMER2.0 for analysis of tumor-infiltrating immune cells, Nucleic Acids Res., 48, W509, 10.1093/nar/gkaa407 Chen, 2018, Profiling Tumor Infiltrating Immune Cells with CIBERSORT, Methods Mol. Biol., 1711, 243, 10.1007/978-1-4939-7493-1_12 Zhang, 2020, Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients, Ann Surg. Aran, 2020, Cell-Type Enrichment Analysis of Bulk Transcriptomes Using xCell, Methods Mol. Biol., 2120, 263, 10.1007/978-1-0716-0327-7_19 Aran, 2017, xCell: digitally portraying the tissue cellular heterogeneity landscape, Genome Biol., 18, 220, 10.1186/s13059-017-1349-1 Finotello, 2019, Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data, Genome Med., 11, 34, 10.1186/s13073-019-0638-6 Plattner, 2020, Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq, Methods Enzymol., 636, 261, 10.1016/bs.mie.2019.05.056 Dienstmann, 2019, Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer, Ann. Oncol., 30, 1622, 10.1093/annonc/mdz287 Racle, 2017, Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data, eLife, 6, e26476, 10.7554/eLife.26476 Tamminga, 2020, Immune microenvironment composition in non-small cell lung cancer and its association with survival, Clin. Transl. Immunology, 9, e1142, 10.1002/cti2.1142 Dai, 2020, Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis, Oncol. Lett., 19, 388 Yue, 2019, Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer, BMC Cancer, 19, 1266, 10.1186/s12885-019-6470-y Wu, 2020, Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets, PeerJ, 8, e8961, 10.7717/peerj.8961 Zhang, 2020, m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer, Mol. Cancer, 19, 53, 10.1186/s12943-020-01170-0